Vaping EU Regulations Report Released by ResearchAndMarkets.com

Oct.11.2022
Vaping EU Regulations Report Released by ResearchAndMarkets.com
ResearchAndMarkets.com added a report on vaping regulations in the EU, allowing easy information filtering and comparison.

A report titled "Vaping EU Restrictions, Requirements, and Sanctions Database" has been added to the ResearchAndMarkets.com product lineup. The report provides important electronic cigarette regulations in Europe, allowing individuals to easily filter and compare relevant information. With this important tool, interested parties can find regulations applicable to various EU member states, the UK, Iceland, Norway, and Switzerland.


The report provides necessary insights into various aspects of the e-cigarette industry, through specific regulations, requirements, limitations, and expert analysis based on firsthand data collected from legislators and industry professionals of particular nations. A press release explained the report's aim to clarify this dispersed industry.


The report contains the following main sections:


New Regulations on Products and Retail: The TPD Notification, Related Proposals and Tax Penalties, Public Space Advertising and Marketing Laws. The regulations cover various areas of regulation related to products and retail, including limitations on advertising and marketing in public spaces.


Product packaging and labeling restrictions limit retail sales.


Report provided:


To effectively operate in different areas of the vaping industry, it is crucial to have an understanding of the regulations, requirements, and limitations of specific countries or regions. The most important restrictions in the proposed policy areas can be summarized and classified through color-coded tables. Comprehensive data is available to accurately interpret this fragmented industry. Each country's current regulations are compiled in one place. Links to external sources for regulations and recommendations are also provided. Experts have analyzed the information.


Key themes covered:


Product and retail restrictions:


The TPD product notification concerns proposals related to taxation and sanctions on advertising and marketing in public places, as well as packaging and labeling laws for products. The promotional material for Zhongdian Healthy Warning Leaflets is available in multiple packs and individually wrapped units, with zero nicotine. Meanwhile, the EU's Commissioner for Health and Food Safety, Stella Kyriakides, has made a statement questioning the effectiveness of e-cigarettes as a smoking cessation aid and even suggesting that they may serve as a gateway to smoking, spreading false information about e-cigarettes.


Michael Landl, director of the World Vapers' Alliance (WVA), expressed his disappointment that the European Commission continues to ignore the scientific evidence on e-cigarettes and make statements despite it. "It is shocking that the Commission is still peddling outdated and debunked theories," Landl said. "The Commission has systematically ignored vast scientific evidence pointing to the benefits of e-cigarettes, not to mention the firsthand experiences of millions of vapers. E-cigarettes are 95% less harmful than smoking and are a more effective smoking cessation method than traditional therapies such as gum and patches. The commission's approach to e-cigarettes will only cost lives.


The problematic statement is a written response to MEP Sara Skyttedal's inquiry about the future treatment of electronic and nasal snuff and their place in Europe's anti-cancer plan. "Overall, smokeless tobacco and emerging tobacco and related products contain nicotine, a toxic and highly addictive substance - known to cause significant health consequences - and they prolong nicotine addiction times. This is why these products are regulated and oral tobacco is banned in the EU," the statement concludes.


Sadly, Commissioner Kyriakides did not consider the scientific issues regarding nicotine and instead chose to ignore opinions from experts and consumers. A statement reveals that the European Commission intends to crack down on e-cigarettes, which is not a promising indication for the upcoming Tobacco Products Directive update. This strengthens the belief that consumers need to speak up and convince the representatives in the European Parliament to reduce harm, added Randall.


Statement:


This article was compiled based on third-party information and is intended solely for industry discussions and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry communication and research.


Due to the limitations of the translating ability, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong-Macao-Taiwan-related, and foreign issues and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Exclusive: Glas says FDA-authorized G2 vape includes age-gating technology
Glas has confirmed to 2Firsts that its G2 device, which received a FDA Marketing Granted Order (MGO), incorporates age-gating technology. Based on currently public information, this means the FDA has granted an MGO to the first ENDS product confirmed to incorporate age-gating technology, validating 2Firsts’ earlier inference.
Mar.17
Nigeria’s House of Representatives Plans to Amend the National Tobacco Control Act to Close Regulatory Gaps on E-cigarettes and Other Emerging Nicotine Products
Nigeria’s House of Representatives Plans to Amend the National Tobacco Control Act to Close Regulatory Gaps on E-cigarettes and Other Emerging Nicotine Products
Nigeria’s House of Representatives said it will review the National Tobacco Control Act to address regulatory gaps around emerging nicotine products such as e-cigarettes and to strengthen border controls and enforcement coordination. A relevant committee visited the headquarters of the Nigeria Customs Service, stressing linkage and cooperation among the NDLEA, NAFDAC and Customs.
Feb.26 by 2FIRSTS.ai
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
Police said detections of new drugs disguised as e-cigarettes reached 1,206 cases through September last year, up from 941 in 2022, and the number of detected drug types increased from 26 to 33 over the same period.
Feb.11 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.
Mar.13 by 2FIRSTS.ai
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai